New findings show that Ibrance has the potential to help patients with brain metastases that harbor a CDK pathway alteration.
Dr. Pamela Brastianos
Advertisement
Articles by Dr. Pamela Brastianos
Advertisement
Latest Updated Articles
Ibrance Shows Promise in Patients with Brain Metastases Who Harbor a CDK Pathway AlterationPublished: December 19th 2019 | Updated:
Advertisement
Advertisement
Trending on CURE
1
Peritoneal Mesothelioma Survivor Shares Ongoing Reality of Survivorship
2
What Does a Stage 2 Prostate Cancer Diagnosis Mean for Me?
3
SUNRiSE-1 Participant Shares Insights on Bladder Cancer Education
4
Becoming Cancer-Aware: How My Diagnosis Changed the Way My Family Sees Everyday Products
5
